ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Schedule of Consideration for RayzeBio Acquisition (Details) - RayzeBio - USD ($) $ in Millions		9 Months Ended
	Feb. 26, 2024	Sep. 30, 2024
Business Combination [Line Items]
Total consideration	$ 4,147
Total consideration allocated	3,873
Common Stock
Business Combination [Line Items]
Total consideration	3,851
Equity
Business Combination [Line Items]
Total consideration	296
Unvested Equity Awards
Business Combination [Line Items]
Total consideration	$ 274
Unvested Equity Awards | Selling, general and administrative
Business Combination [Line Items]
Total consideration		$ 159
Unvested Equity Awards | Research and development
Business Combination [Line Items]
Total consideration		$ 115